{"id":3390,"date":"2024-04-16T08:28:19","date_gmt":"2024-04-16T08:28:19","guid":{"rendered":"https:\/\/pharm.sinocurechem.com\/?p=3301"},"modified":"2026-09-10T03:06:41","modified_gmt":"2026-09-10T03:06:41","slug":"how-protionamides-breakthrough-mechanism-is-revolutionizing-tuberculosis-treatment","status":"publish","type":"post","link":"https:\/\/longchangextracts.com\/da\/how-protionamides-breakthrough-mechanism-is-revolutionizing-tuberculosis-treatment\/","title":{"rendered":"Prothionamid (CAS 14222-60-7): Identitetsbekr\u00e6ftelse og teknisk gennemgang"},"content":{"rendered":"
\n

Prothionamide (CAS 14222-60-7): Correct Identity and Technical Review<\/h1>\n

Prothionamide, also spelled protionamide, is a thioamide compound identified by CAS 14222-60-7. PubChem CID 666418<\/a> records its molecular formula as C9<\/sub>H12<\/sub>N2<\/sub>S and molecular weight as 180.27 g\/mol.<\/p>\n

Correct chemical identity<\/h2>\n

The systematic name is 2-propylpyridine-4-carbothioamide. Its structure contains a pyridine ring and a carbothioamide group. It should not be described as a thiazole with a carbonyl group. That distinction matters when checking analytical data, a structure drawing or a specification supplied under a similar name.<\/p>\n\n\n\n\n\n\n\n\n\n
Field<\/th>\nReference identity<\/th>\n<\/tr>\n<\/thead>\n
Name<\/th>\nProthionamide \/ protionamide<\/td>\n<\/tr>\n
CAS<\/th>\n14222-60-7<\/td>\n<\/tr>\n
Formula<\/th>\nC9<\/sub>H12<\/sub>N2<\/sub>S<\/td>\n<\/tr>\n
Molecular weight<\/th>\n180.27 g\/mol<\/td>\n<\/tr>\n
Public record<\/th>\nPubChem CID 666418<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Medical references and their limits<\/h2>\n

Prothionamide appears in antituberculosis drug references. Such references do not provide a general-purpose treatment plan for a reader or establish that a raw chemical may be used as a medicine. Tuberculosis treatment depends on resistance, the individual patient and current clinical guidance. It requires specialist medical supervision.<\/p>\n

This website does not recommend a regimen or provide dosing instructions. A supplier description cannot establish current first-line or second-line treatment status in every country. Use current authoritative clinical guidance and the approved information for the actual finished medicine when making professional treatment decisions.<\/p>\n

Why a structure check belongs in procurement<\/h2>\n

A name or CAS number should agree across the quotation, label, COA and reference structure. Compare the molecular formula and material form before interpreting analytical results. If a formula, molecular weight or functional-group description conflicts with the structural record, resolve that discrepancy with the supplier before proceeding.<\/p>\n

Identity records do not determine the grade or impurity profile of a particular lot. Request the analytical methods, acceptance limits, reference-standard basis and batch documentation appropriate to the intended professional use.<\/p>\n

Questions for technical evaluation<\/h2>\n